GC31496
DO34 analog
Also known as tert-butyl 3-benzyl-4-[4-[4-(trifluoromethoxy)phenyl]triazole-2-carbonyl]piperazine-1-carboxylate
DO34 analog is a triazole DAGL(α) inhibitor extracted from patent WO2017096315 A1, compound 100
ChemicalCAS2098969-71-0MW531.53FormulaC26H28F3N5O4
- CAS number
- 2098969-71-0
- Molecular weight
- 531.53
- Formula
- C26H28F3N5O4
- Solubility
- DMSO ： ≥ 105 mg/mL (197·54 mM)
- InChIKey
- ZCLTTXIIPQGUKN-UHFFFAOYSA-N
- Catalogue number
- GC31496
- Brand
- GLPBIO
Computed properties PubChem CID 129201716 · XLogP 5.7 · TPSA 89.8 Ų · H-bond donors 0
- XLogP
- 5.7
- TPSA
- 89.8 Ų
- H-bond donors
- 0
- H-bond acceptors
- 9
- Rotatable bonds
- 6
- Heavy atoms
- 38
SMILES CC(C)(C)OC(=O)N1CCN(C(C1)CC2=CC=CC=C2)C(=O)N3N=CC(=N3)C4=CC=C(C=C4)OC(F)(F)F
Computed descriptors from PubChem (CID 129201716), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il